925 followers
New article: A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma. https://t.co/YXs0AFfWT7 #DLBCL #lymsm #hematology
New article: A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma. https://t.co/YXs0AFfWT7 #DLBCL #lymsm #hematology